ketoconazole and remogliflozin etabonate

ketoconazole has been researched along with remogliflozin etabonate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowers, GD; Castellino, S; Culp, AG; Dobbins, RL; Humphreys, JE; Hussey, EK; Kapur, A; O'Connor Semmes, RL; Polli, JW; Reese, MJ; Sigafoos, JF; Tao, W; Wagner, DS1

Trials

1 trial(s) available for ketoconazole and remogliflozin etabonate

ArticleYear
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:11

    Topics: Administration, Oral; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Glucosides; Glucuronides; Half-Life; Humans; Ketoconazole; Male; Microsomes, Liver; Middle Aged; Pyrazoles; Risk; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult

2012